CLOV Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
759.3M
+2.2%
743.2M
-0.8%
749.2M
+53.6%
487.7M
-1.8%
496.6M
Cost of Revenue
629.5M
+6.7%
590.2M
+0.1%
589.6M
+42.6%
413.5M
-2.4%
423.5M
Gross Profit
129.8M
-15.1%
153.0M
-4.1%
159.5M
+115.0%
74.2M
+1.4%
73.2M
Operating Expenses
123.4M
-1.3%
125.0M
-5.5%
132.2M
+7.0%
123.5M
+26.6%
97.6M
R&D
0
0
0
0
0
SG&A
122.8M
-1.3%
124.4M
-5.5%
131.7M
+7.0%
123.1M
+26.7%
97.1M
Operating Income
6.4M
-77.0%
28.0M
+2.4%
27.3M
+155.4%
-49319000
-102.3%
-24377000
EBITDA
6.6M
-76.5%
28.1M
+2.7%
27.4M
+155.5%
-49400000
-102.7%
-24367000
Net Income
6.4M
-77.0%
28.0M
+2.4%
27.3M
+155.4%
-49320000
-102.3%
-24377000
EPS (Basic)
$0.01
-80.0%
$0.05
+0.0%
$0.05
+155.6%
$-0.09
-80.0%
$-0.05
EPS (Diluted)
$0.01
-80.0%
$0.05
+0.0%
$0.05
+155.6%
$-0.09
-80.0%
$-0.05
Shares (Diluted)
557.5M
+2.2%
545.4M
+2.4%
532.5M
+0.7%
529.0M
+3.2%
512.7M
Clover Health Investments (CLOV) — Financials